Iovance Biotherapeutics I... (IOVA)
NASDAQ: IOVA
· Real-Time Price · USD
2.54
0.09 (3.67%)
At close: Aug 15, 2025, 3:59 PM
2.55
0.20%
After-hours: Aug 15, 2025, 07:57 PM EDT
Iovance Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -111.66M | -116.16M | -78.56M | -83.54M | -97.1M | -112.98M | -116.38M | -113.76M | -106.53M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M | -86.12M | -81.35M | -75.45M |
Depreciation & Amortization | 11.94M | 11.06M | 11.69M | 2.16M | 10.86M | 9.91M | 9.71M | 9.88M | 7.84M | 5.7M | 5.71M | 5.2M | 5.25M | 4.98M | 12.21M | 1.03M | 366K | 372K |
Stock-Based Compensation | 14.94M | 22.91M | 30.98M | 31.01M | 30.47M | 17.18M | 14.4M | 15.82M | 16.74M | 15.66M | 19.51M | 19.78M | 22.47M | 22.27M | 19.1M | 19.31M | 14.41M | 16.94M |
Other Working Capital | -9.64M | -4.11M | -4.88M | 7.28M | 11.91M | -19.92M | 1.39M | 15.27M | -2.03M | -3.02M | 1.45M | 6.59M | -8.63M | -8.19M | 13.24M | 7.25M | 5.68M | -8.59M |
Other Non-Cash Items | 6.15M | -2.04M | -981K | -78.33M | -2.49M | -2.43M | -1.83M | -666K | -58K | -978K | -571K | 4.39M | 454K | 855K | -3.68M | 5.22M | 122K | 2.29M |
Deferred Income Tax | 1.99M | -1.84M | 1.56M | -1.52M | -1.46M | -1.41M | -1.76M | -1.24M | -477K | n/a | n/a | n/a | n/a | n/a | -3.11M | 1.31M | 1.8M | 2.07M |
Change in Working Capital | 9.19M | -17.63M | -37.98M | 71.26M | -38.71M | -32.55M | 11.89M | 5.89M | -11.47M | -12.83M | 3M | 10.85M | -6.46M | -10.29M | 20.96M | 1.56M | 10.64M | -8.61M |
Operating Cash Flow | -67.45M | -103.69M | -73.3M | -58.97M | -98.43M | -122.28M | -83.97M | -84.08M | -93.95M | -99.81M | -77.67M | -63.65M | -77.64M | -73.8M | -53.85M | -57.69M | -54.01M | -62.39M |
Capital Expenditures | -7.46M | -6.21M | -4.17M | -2.29M | -442K | -4.17M | -3.53M | -3.58M | -9.52M | -5.66M | -3.02M | -1.39M | -4.58M | -11.44M | -7.57M | -9.69M | -9.62M | -10.71M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -52.57M | 253K | -3.38M | -209.51M | -159.06M | -3.48M | n/a | -100.34M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -68.7M | -97.92M | -88.16M | -156.51M | -74.34M | -141.76M | -107.57M | -93.01M | 209.51M | -5.32M | -95.63M | -64.35M | -40.29M | -45.55M | -141.55M | -201.87M | -311.41M | -70.37M |
Sales Maturities Of Investments | 90M | 120M | 116M | 110M | 115M | 87M | 38M | 20.95M | 62.25M | 164.38M | 99.11M | 139.45M | 140.63M | 143.51M | 218.46M | 224.3M | 161.87M | 158.29M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -209.51M | 159.06M | 3.48M | 75.1M | 100.34M | 97.96M | 76.91M | 22.43M | -149.55M | 87.92M |
Investing Cash Flow | 13.84M | 15.87M | 23.68M | -48.8M | 40.22M | -111.51M | -72.84M | -79.01M | -156.78M | 153.4M | 461K | 73.72M | 95.76M | 86.52M | 69.34M | 12.75M | -159.16M | 77.21M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -301K | n/a | n/a | n/a | -2.65M | n/a | 1.59M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 165K | -5.63M | 399.98M | -5.56M | 952K | -4.7M | 961K | -379K | 1.02M | -1.93M | 1.07M | 225K | -2.07M | 1.42M | 4.15M | 20.77M | 3.71M | 6.48M |
Financial Cash Flow | 13.23M | 143.31M | 2.31M | 41.95M | 152.82M | 193.58M | 962K | 202.8M | 1.02M | 258.17M | 190.57M | 225K | -2.07M | 1.42M | 4.15M | 20.77M | 163.98M | 50.36M |
Net Cash Flow | -39.64M | 56M | -48.49M | -64.57M | 94.56M | -40.7M | -152.83M | 37.71M | -253.47M | 311.75M | 113.36M | 10.29M | 16.06M | 14.13M | 19.64M | -24.17M | -49.19M | 65.18M |
Free Cash Flow | -74.91M | -109.91M | -77.46M | -61.26M | -98.87M | -126.45M | -87.5M | -87.66M | -103.47M | -105.48M | -80.69M | -65.04M | -82.21M | -85.24M | -61.42M | -67.38M | -63.62M | -73.1M |